Cargando…

Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?

BACKGROUND AND AIM: Although the clinicopathological significance of the expression of programmed death ligand 1(PD‐L1) in various cancer tissues has been reported, serum PD‐L1 level has not been evaluated in patients with surgically treated gastric cancer. Therefore, we evaluated the clinicopatholo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Masaaki, Oshima, Yoko, Yajima, Satoshi, Suzuki, Takashi, Nanami, Tatsuki, Shiratori, Fumiaki, Funahashi, Kimihiko, Nemoto, Tetsuo, Shimada, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036390/ https://www.ncbi.nlm.nih.gov/pubmed/30003194 http://dx.doi.org/10.1002/ags3.12175

Ejemplares similares

Preoperative Low Serum Calcium Levels Predict Poor Prognosis for Patients with Esophageal Cancer
por: Shiratori, Fumiaki, et al.
Publicado: (2021)

Is High Score of Preoperative Lactate Dehydrogenase to Albumin Ratio Predicting Poor Survivals in Esophageal Carcinoma Patients?
por: Shiratori, Fumiaki, et al.
Publicado: (2023)

Diagnostic impact of high serum midkine level in patients with gastric cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Randomized Phase II Study to Comparing Docetaxel/Nedaplatin versus Docetaxel for 5-Fluorouracil/Cisplatin Resistant Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2021)

Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer
por: Ito, Masaaki, et al.
Publicado: (2022)

Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker
por: Nanami, Tatsuki, et al.
Publicado: (2021)

Does Preoperative Low HbA1c Predict Esophageal Cancer Outcomes?
por: Kochi, Ryosuke, et al.
Publicado: (2019)

The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
por: Ito, Masaaki, et al.
Publicado: (2023)

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
por: Ito, Masaaki, et al.
Publicado: (2021)

Comparison between a new assay system, Elecsys(®) Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study
por: Suzuki, Takashi, et al.
Publicado: (2022)

Neck Dissection for Thoracic Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2012)

Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancer
por: Ushigome, Mitsunori, et al.
Publicado: (2021)

Prognostic impact of p53 and/or NY‐ESO‐1 autoantibody induction in patients with gastroenterological cancers
por: Hoshino, Isamu, et al.
Publicado: (2020)

A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients
por: Sumazaki, Makoto, et al.
Publicado: (2020)

A case of Barrett’s esophageal cancer with gastric mucosa-associated lymphoma
por: Shiratori, Fumiaki, et al.
Publicado: (2020)

Preoperative CRP(−)/CEA(−)/CA19-9(−)/non-T4 in Stage III Colorectal Cancer Is Favorable Risk for Recurrence
por: Ushigome, Mitsunori, et al.
Publicado: (2022)

The Outcome of Conversion to Hand-Assisted Laparoscopic Surgery in Laparoscopic Liver Resection
por: Nakada, Shinichiro, et al.
Publicado: (2023)

Novel cancer‐specific epidermal growth factor receptor antibody obtained from the serum of esophageal cancer patients with long‐term survival
por: Takagi‐Maeda, Sayaka, et al.
Publicado: (2022)

Programmed death‐ligand 1 expression at tumor invasive front is associated with epithelial‐mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma
por: Tsutsumi, Satoshi, et al.
Publicado: (2017)

Chemoradiation therapy with S-1 for primary squamous cell carcinoma of the rectum: report of three cases
por: Funahashi, Kimihiko, et al.
Publicado: (2015)

Expression of programmed death ligand-1 predicts poor outcome in nasopharyngeal carcinoma
por: Li, Ying-Fei, et al.
Publicado: (2017)

Programmed Death Ligand 1: A Poor Prognostic Marker in Endometrial Carcinoma
por: Chew, Mianxin, et al.
Publicado: (2020)

Clinical evaluation of salivary periodontal pathogen levels by real-time polymerase chain reaction in patients before dental implant treatment
por: Ito, Taichi, et al.
Publicado: (2014)

A role of (18)F-fluorodeoxyglucose positron emission/computed tomography in a strategy for abdominal wall metastasis of colorectal mucinous adenocarcinoma developed after laparoscopic surgery
por: Funahashi, Kimihiko, et al.
Publicado: (2011)

Inducing multiple antibodies to treat squamous cell esophageal carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020)

Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C
por: Yamagiwa, Satoshi, et al.
Publicado: (2017)

Ezrin Modulates the Cell Surface Expression of Programmed Cell Death Ligand-1 in Human Cervical Adenocarcinoma Cells
por: Tanaka, Chihiro, et al.
Publicado: (2021)

Changes in antimicrobial resistance phenotypes and genotypes in Streptococcus suis strains isolated from pigs in the Tokai area of Japan
por: ICHIKAWA, Takashi, et al.
Publicado: (2019)

Clinical characteristics of older Japanese patients with acute appendicitis: A post hoc analysis
por: Sasaki, Yosuke, et al.
Publicado: (2021)

Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection
por: Kwon, Mi Jung, et al.
Publicado: (2017)

Effects of Olmesartan‐Based Treatment on Masked, White‐Coat, Poorly Controlled, and Well‐Controlled Hypertension: HONEST Study
por: Kario, Kazuomi, et al.
Publicado: (2014)

The metabolic parameters based on volume in PET/CT are associated with clinicopathological N stage of colorectal cancer and can predict prognosis
por: Kido, Hidenori, et al.
Publicado: (2021)

Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients
por: Gu, Xiaobin, et al.
Publicado: (2016)

High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma
por: Lu, Tianzhu, et al.
Publicado: (2020)

Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
por: Zhang, Yang, et al.
Publicado: (2014)

Transanal down-to-up dissection of the distal rectum as a viable approach to achieve total mesorectal excision in laparoscopic sphincter-preserving surgery for rectal cancer near the anus: a study of short- and long-term outcomes of 123 consecutive patients from a single Japanese institution
por: Kagami, Satoru, et al.
Publicado: (2022)

A nationwide, multi‐institutional collaborative retrospective study of colorectal neuroendocrine tumors in Japan
por: Yamaguchi, Tatsuro, et al.
Publicado: (2020)

Long-term assessment of anorectal function after extensive resection of the internal anal sphincter for treatment of low-lying rectal cancer near the anus
por: Shiokawa, Hiroyuki, et al.
Publicado: (2018)

Role of Ezrin/Radixin/Moesin in the Surface Localization of Programmed Cell Death Ligand-1 in Human Colon Adenocarcinoma LS180 Cells
por: Kobori, Takuro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0hn8umcl9p4i3aoep334vbm5is